Chemical injury treated with autologous limbal epithelial stem cell transplantation and subconjunctival bevacizumab.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4156003)

Published in Clin Ophthalmol on August 30, 2014

Authors

Gian Maria Cavallini1, Graziella Pellegrini2, Veronica Volante1, Pietro Ducange1, Michele De Maria1, Giulio Torlai1, Caterina Benatti1, Matteo Forlini1

Author Affiliations

1: Institute of Ophthalmology, University of Modena e Reggio Emilia, Modena, Italy.
2: Centre for Regenerative Medicine "Stefano Ferrari", University of Modena e Reggio Emilia, Modena, Italy.